To hear about similar clinical trials, please enter your email below
Trial Title:
Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors
NCT ID:
NCT05799898
Condition:
Cancer
Immune Checkpoint Inhibitor
Cardiovascular Complication
Immune-related Adverse Event
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
No intervention for research purposes only
Description:
No intervention for research purposes only
Summary:
Prospective study cohort on patients addressed for suspected cardiovascular event on
immune checkpoint inchibitors.
Longitudinal prospective single center cohort. Inclusion criteria: all patient willing to
particiupate seen in the cardio-oncology unit at our institution for the suspicion of
heart failure, atherosclerosis related event, Tako Tsubo, arrhymias, pericarditis,
myocarditis on antiPD1, antiPDL1, or antiCTLA4 immune checkpoint inhibitors.
Description of patients characteristics, investigations, diagnosis after
multidisciplinary meeting, outcomes.
Criteria for eligibility:
Study pop:
Adults on immune checkpoint inhibitors for cancer treatment
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- all patient referred to the cardio oncology unit for suspected immune related
cardiovascular complication on immune checkpoint inhibitors
Exclusion Criteria:
- none
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Intitut Mutualiste Montsouris
Address:
City:
Paris
Zip:
75014
Country:
France
Status:
Recruiting
Contact:
Last name:
Mariana Mirabel, MD, PhD
Phone:
+33156616479
Email:
mariana.mirabel@imm.fr
Contact backup:
Last name:
Isabelle Sauret, MBs
Phone:
+33156616705
Email:
isabelle.sauret@imm.fr
Start date:
March 1, 2022
Completion date:
January 1, 2030
Lead sponsor:
Agency:
Institut Mutualiste Montsouris
Agency class:
Other
Source:
Institut Mutualiste Montsouris
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05799898
